Gaush Meditech Ltd (2407.HK) AI-Powered Stock Analysis
See how Gaush Meditech Ltd scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.
2407.HK●HKSE
HealthcareMedical - Devices
HK$4.90
HK$0.10(2.00%)
Hong Kong Market opens in 41h 52m
Gaush Meditech Ltd (2407.HK)
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full DisclaimerGaush Meditech Ltd (2407.HK) Stock Overall Grade
Gaush Meditech Ltd’s grade based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
Z
Grade Breakdown by Metric
See how each financial and market factor contributes to Gaush Meditech Ltd's overall stock rating.
Forecast
C+Score
55/100Financial Growth
CScore
40/100Fundamental Growth
CScore
41/100Key Ratios
A+Score
90/100Sector Comparison
AScore
85/100Industry Comparison
C+Score
50/100S&P 500 Benchmark
A+Score
98/100Analyst Consensus
C+Score
50/100Gaush Meditech Ltd (2407.HK) AI-Powered Stock Analysis
This asset demonstrates Good performance with an overall Forecast Score of 55/100 (C+), reflecting weak confidence in its potential. Financial Growth (40/100, C) and Fundamental Growth (41/100, C) highlight its stability, while Key Ratios (90/100, A+) and Sector Comparison (85/100, A) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (98/100, A+), it shows competitive strength. Analyst Consensus (50/100,C+) suggests High divergence in outlook.Component Analysis Explained
Understand the key factors behind each Gaush Meditech Ltd stock grade, including financials, comparisons, and forecasts.